UNSPSC 51201606: Hemophilus influenzae vaccine

This classification denotes a vaccine for a species of haemophilus found on the mucous membranes of humans and a variety of animals, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 2495X8VZXG.

UNSPSC 51201606 Hemophilus influenzae vaccine is a Commodity code that encompasses immunizations procured by state and local health departments. The code captures vaccines purchased for public health programs, including routine immunization campaigns and emergency procurement. State health departments are the primary issuing bodies under this code, soliciting vaccines through both competitive bids and, where justified, sole source procurements when clinical or supply-chain factors support exclusivity.

Recent activity shows limited visibility, with a single posted opportunity in the source record. The Mississippi State Department of Health posted a sole source notice for Yellow Fever Vaccine from Sanofi Pasteur on July 13, 2026, with an objection deadline of August 3, 2026, though this vaccine falls outside the Hemophilus influenzae scope nominally tagged to the code. The mismatch suggests that state procurement systems may use broad vaccine codes or catalog errors when tagging immunization solicitations. Geographic spread is narrow in the available record; Mississippi is the only named issuing body. No quantity, contract term, pricing, or estimated value was disclosed in the published notice.